Description

Want to improve your problem solving and teamworking by unlocking your creative skills?

Curious how play and physical exploration of your ideas can be the key to your next innovative breakthrough?

Join us for the first workshop of ACE Saturdays 2019 - BioEscalator Business Toolkit to learn new skills with like-minded colleagues in a fun and interactive way. 

Join us for a half-day event to develop your skills in 

• Problem solving
• Team working
• Communicating
• Decision making 
• Knowledge sharing

with the LEGO® Serious Play® methodology and led by facilitator Emad Saif.

On the Day

LEGO® Serious Play® is a facilitated meeting, communication and problem-solving method, where participants are led through a series of questions, which go deeper and deeper. Each participant builds their own three-dimensional LEGO model in response to the facilitator’s questions using specially selected LEGO bricks. These 3D models serve as the basis for group discussion, knowledge sharing, problem solving and decision-making.

The workshop is split into multiple activities to constantly challenge individuals and teams to create “Aha” moments over the course of the day. There are three phases throughout the day:

09:30-10.15: Registration

10:15-10:30: Welcome from Innovation Forum Oxford

10:30-10:45: Introduction to Lego® Serious Play®

10:45-11:30: SESSION I - Skill Building

11:30-12:30: SESSION II - Unlocking Deep Knowledge

12:30-13:00: Lunch and Networking

13:00-14:00: SESSION III - Forming Shared Understanding

14:00-14:30: SESSION IV - Reflection and Conclusion

Speaker

Emad Saif is a lecturer at the College of Business & Economics at Qatar University and is a certified facilitator in Lego® Serious Play®.

This event is hosted in partnership with the Oxford BioEscalator
The BioEscalator is a hub for new and developing life science innovations, with flexible lab space is available for small and growing biomedical science companies.

This 2019 series is also supported by University of Oxford KE Seed Fund, MRC Proximity to Discovery fund, and the University of Oxford Medical Sciences Division.